GSK subsidiary wins FDA approval for new HIV treatment

... that our singular focus on HIV can deliver important new medicines, maintaining our absolute commitment to the HIV/AIDS global response." The submission included data from four Phase III clinical trials that treated 2,557 adults (who received at ...

http://www.livecharts.co.uk/share_prices/GSK-subsidiary-wins-FDA-approval-for-new-HIV--news21089245.html